225 related articles for article (PubMed ID: 26859151)
1. Differential Roles for DUSP Family Members in Epithelial-to-Mesenchymal Transition and Cancer Stem Cell Regulation in Breast Cancer.
Boulding T; Wu F; McCuaig R; Dunn J; Sutton CR; Hardy K; Tu W; Bullman A; Yip D; Dahlstrom JE; Rao S
PLoS One; 2016; 11(2):e0148065. PubMed ID: 26859151
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of dual specificity phosphatase 4 enhances the chemosensitivity of MCF-7 and MCF-7/ADR breast cancer cells to doxorubicin.
Liu Y; Du F; Chen W; Yao M; Lv K; Fu P
Exp Cell Res; 2013 Dec; 319(20):3140-9. PubMed ID: 24012960
[TBL] [Abstract][Full Text] [Related]
3. Regulation of Dual-Specificity Phosphatase (DUSP) Ubiquitination and Protein Stability.
Chen HF; Chuang HC; Tan TH
Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31151270
[TBL] [Abstract][Full Text] [Related]
4. LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancer.
Boulding T; McCuaig RD; Tan A; Hardy K; Wu F; Dunn J; Kalimutho M; Sutton CR; Forwood JK; Bert AG; Goodall GJ; Malik L; Yip D; Dahlstrom JE; Zafar A; Khanna KK; Rao S
Sci Rep; 2018 Jan; 8(1):73. PubMed ID: 29311580
[TBL] [Abstract][Full Text] [Related]
5. Chromatinized protein kinase C-θ directly regulates inducible genes in epithelial to mesenchymal transition and breast cancer stem cells.
Zafar A; Wu F; Hardy K; Li J; Tu WJ; McCuaig R; Harris J; Khanna KK; Attema J; Gregory PA; Goodall GJ; Harrington K; Dahlstrom JE; Boulding T; Madden R; Tan A; Milburn PJ; Rao S
Mol Cell Biol; 2014 Aug; 34(16):2961-80. PubMed ID: 24891615
[TBL] [Abstract][Full Text] [Related]
6. Impaired Dual-Specificity Protein Phosphatase DUSP4 Reduces Corticosteroid Sensitivity.
Kobayashi Y; Ito K; Kanda A; Tomoda K; Mercado N; Barnes PJ
Mol Pharmacol; 2017 May; 91(5):475-481. PubMed ID: 28283554
[TBL] [Abstract][Full Text] [Related]
7. Identification of chromatin accessibility domains in human breast cancer stem cells.
Hardy K; Wu F; Tu W; Zafar A; Boulding T; McCuaig R; Sutton CR; Theodoratos A; Rao S
Nucleus; 2016; 7(1):50-67. PubMed ID: 26962893
[TBL] [Abstract][Full Text] [Related]
8. DUSP5 and DUSP6 modulate corneal epithelial cell proliferation.
Wang Z; Reinach PS; Zhang F; Vellonen KS; Urtti A; Turner H; Wolosin JM
Mol Vis; 2010 Aug; 16():1696-704. PubMed ID: 20806045
[TBL] [Abstract][Full Text] [Related]
9. Activation of MAPK pathways due to DUSP4 loss promotes cancer stem cell-like phenotypes in basal-like breast cancer.
Balko JM; Schwarz LJ; Bhola NE; Kurupi R; Owens P; Miller TW; Gómez H; Cook RS; Arteaga CL
Cancer Res; 2013 Oct; 73(20):6346-58. PubMed ID: 23966295
[TBL] [Abstract][Full Text] [Related]
10. Wnt/β-catenin pathway is required for epithelial to mesenchymal transition in CXCL12 over expressed breast cancer cells.
Shan S; Lv Q; Zhao Y; Liu C; Sun Y; Xi K; Xiao J; Li C
Int J Clin Exp Pathol; 2015; 8(10):12357-67. PubMed ID: 26722422
[TBL] [Abstract][Full Text] [Related]
11. DUSP 4 expression identifies a subset of colorectal cancer tumors that differ in MAPK activation, regardless of the genotype.
De Vriendt V; De Roock W; Di Narzo AF; Tian S; Biesmans B; Jacobs B; Budinska E; Sagaert X; Rossi S; D'Ario G; Delorenzi M; Simon I; Vecchione L; Tejpar S
Biomarkers; 2013 Sep; 18(6):516-24. PubMed ID: 23875912
[TBL] [Abstract][Full Text] [Related]
12. Differential expression profiles and roles of inducible DUSPs and ERK1/2-specific constitutive DUSP6 and DUSP7 in microglia.
Ham JE; Oh EK; Kim DH; Choi SH
Biochem Biophys Res Commun; 2015 Nov; 467(2):254-60. PubMed ID: 26435497
[TBL] [Abstract][Full Text] [Related]
13. miR-137 alleviates doxorubicin resistance in breast cancer through inhibition of epithelial-mesenchymal transition by targeting DUSP4.
Du F; Yu L; Wu Y; Wang S; Yao J; Zheng X; Xie S; Zhang S; Lu X; Liu Y; Chen W
Cell Death Dis; 2019 Dec; 10(12):922. PubMed ID: 31801953
[TBL] [Abstract][Full Text] [Related]
14. DUSP4 Inactivation Leads to Reduced Extracellular Signal‒Regulated Kinase Activity through Upregulation of DUSP6 in Melanoma Cells.
Kamada H; Yasuhira S; Shibazaki M; Amano H; Maesawa C
J Invest Dermatol; 2022 Sep; 142(9):2499-2507.e6. PubMed ID: 35189148
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of dual-specificity phosphatases 4 and 13 attenuates transforming growth factor β1-induced migration and drug resistance in A549 cells in vitro.
Guler S; Altunok TH; Sarioglu A; Zik B; Asmaz D; Kayapunar N; Sonmez O; Tepedelen BE; Yalcin A
Biochem Biophys Res Commun; 2022 May; 606():35-41. PubMed ID: 35338857
[TBL] [Abstract][Full Text] [Related]
16. HDAC7 regulates histone 3 lysine 27 acetylation and transcriptional activity at super-enhancer-associated genes in breast cancer stem cells.
Caslini C; Hong S; Ban YJ; Chen XS; Ince TA
Oncogene; 2019 Sep; 38(39):6599-6614. PubMed ID: 31375747
[TBL] [Abstract][Full Text] [Related]
17. Deregulation of DUSP activity in EGFR-mutant lung cancer cell lines contributes to sustained ERK1/2 signaling.
Britson JS; Barton F; Balko JM; Black EP
Biochem Biophys Res Commun; 2009 Dec; 390(3):849-54. PubMed ID: 19836351
[TBL] [Abstract][Full Text] [Related]
18. Regulation of dual specificity phosphatases by fibroblast growth factor signaling pathways in bovine granulosa cells.
Relav L; Price CA
Reproduction; 2021 Oct; 162(5):367-374. PubMed ID: 34486979
[TBL] [Abstract][Full Text] [Related]
19. The emerging roles of dual-specificity phosphatases and their specific characteristics in human cancer.
Gao PP; Qi XW; Sun N; Sun YY; Zhang Y; Tan XN; Ding J; Han F; Zhang Y
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188562. PubMed ID: 33964330
[TBL] [Abstract][Full Text] [Related]
20. Analysis of phosphatases in ER-negative breast cancers identifies DUSP4 as a critical regulator of growth and invasion.
Mazumdar A; Poage GM; Shepherd J; Tsimelzon A; Hartman ZC; Den Hollander P; Hill J; Zhang Y; Chang J; Hilsenbeck SG; Fuqua S; Kent Osborne C; Mills GB; Brown PH
Breast Cancer Res Treat; 2016 Aug; 158(3):441-54. PubMed ID: 27393618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
